Viridian Therapeutics, Inc.\DE (VRDN) Revenue (2013 - 2026)
Viridian Therapeutics, Inc.\DE's Revenue came in at $284,000 for Q2 2026, up 278.7% from $75,000 a year earlier and up 101.4% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Revenue (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Viridian Therapeutics, Inc.\DE reported Revenue of $71.13 million; for FY2025, it came in at $70.85 million.
- Revenue carries a five-year compound annual growth rate of 132.2% (FY2020 to FY2025).
- Going back by year, Revenue was $302,000 in FY2024 (-3.8%), $314,000 in FY2023 (-82.3%), $1.77 million in FY2022 (-40.2%) and $2.96 million in FY2021 (+182.2%).
- The five-year range for quarterly Revenue is $72,000 (Q2 2023) to $70.57 million (Q3 2025).
- Year-over-year, Revenue has increased for three consecutive quarters, with growth averaging 68.8% over the last seven quarters.
- The fastest year-over-year change in Revenue over five years came in Q3 2022 (growth of 474.5%), and the weakest in Q3 2023 (a decline of 94.0%).
- Business Quant data shows VRDN's Revenue at $141,000 (Q1 2026), $132,000 (Q4 2025) and $70.57 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.36 Bn | -752.69 Mn | - | 284,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 284,000.00 |
| Mar 31, 2026 | 141,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 70.57 Mn |
| Jun 30, 2025 | 75,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 72,000.00 |
| Sep 30, 2024 | 86,000.00 |
| Jun 30, 2024 | 72,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Dec 31, 2023 | 72,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 72,000.00 |
| Mar 31, 2023 | 98,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 256,000.00 |
| Mar 31, 2022 | 216,000.00 |
| Dec 31, 2021 | 214,000.00 |
| Sep 30, 2021 | 208,000.00 |
API Access
Viridian Therapeutics, Inc.\DE Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();